BAK
Braskem S.A.
NYSE · Basic Materials · Chemicals · BR
$1.89
−2.58%Year over year
Reported trailing growth
- Revenue
- -9.2%
- EBITDA
- +77.5%
- EBIT
- +2221.4%
- EPS
- +2.0%
- Free cash flow
- -52.7%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -43.6%
- EBITDA
- -42.7%
- EPS
- +97.8%
Three-year CAGR
- Revenue
- -10.4%
- EBITDA
- -57.3%
- EBIT
- —
- Net income
- +14.4%
- EPS
- +14.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026